Kanha Biogenetic
Kanha Biogenetic is an India-based pharmaceutical manufacturer founded in 2006 in Solan, producing tablets, capsules, dry syrups, ointments, food supplements, and nutraceuticals with a workforce of 501-1000 employees.
- Company typePrivate
- Founded2006
- HeadquartersSolan, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Kanha Biogenetic does
Kanha Biogenetic is a privately-held pharmaceutical manufacturer founded in 2006 and headquartered in Solan, India. According to its firmographic profile, the company manufactures tablets, capsules, dry syrups, ointments, food supplements, and nutraceuticals, and operates with a workforce of 501-1000 employees. The combined pharmaceutical and nutraceutical product mix indicates a conventional formulation and supplements manufacturing business rather than a discovery, API, or biologics platform.
Business model specifics are not disclosed in the available inputs. There is no product-level SKU detail, no pricing structure, no customer segmentation, no distribution channel breakdown, no technology stack, and no partnerships or certifications documented. The company's web presence is limited to a placeholder landing page that displays only the company logo and a 'We are working on our Website, We'll be Live soon...' message, with no operational, financial, or commercial information accessible.
As a result, revenue mechanics, go-to-market approach, competitive positioning, and the split between branded generics, contract manufacturing, and own-brand nutraceuticals cannot be substantively characterized from the supplied data. The company is for-profit and private (no public ticker), with no disclosed funding history, ownership structure, management team, or M&A activity in the inputs reviewed.
Kanha Biogenetic firmographics
Firmographics- Name
- Kanha Biogenetic
- Website
- https://kanhabiogenetic.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Kanha Biogenetic is an India-based pharmaceutical manufacturer founded in 2006 in Solan, producing tablets, capsules, dry syrups, ointments, food supplements, and nutraceuticals with a workforce of 501-1000 employees.
- Ownership category
- akta.pro rank
Kanha Biogenetic industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)
Keywords
Where Kanha Biogenetic is headquartered
LocationHeadquarters
- HQ city
- Solan
- HQ country
- India
- HQ region
- Asia
Markets served
Kanha Biogenetic business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Others
Kanha Biogenetic product offering
Product offeringCore offering
Kanha Biogenetic is a pharmaceutical manufacturer that produces tablets, capsules, dry syrups, ointments, food supplements, and nutraceuticals. The company operates a manufacturing facility in Solan, Himachal Pradesh, India, and supplies formulations to business buyers in the pharmaceutical value chain.
Differentiator
Problem solved
Functional benefit
Products and services
- Tablet formulations Oral solid tablet formulations manufactured at the Solan facility for pharmaceutical buyers.
- Capsule formulations Oral solid capsule formulations manufactured at the Solan facility for pharmaceutical buyers.
- Dry syrup formulations Powder-for-oral-suspension (dry syrup) formulations manufactured at the Solan facility for pharmaceutical buyers, commonly used in pediatric and antibiotic products.
- Ointment formulations Topical ointment formulations manufactured at the Solan facility for pharmaceutical buyers.
- Food supplements Food supplement products manufactured at the Solan facility for buyers in the nutritional products value chain.
- Nutraceutical products Nutraceutical products manufactured at the Solan facility for buyers in the nutritional and wellness products value chain.
Companies that use Kanha Biogenetic
Customer profileIdeal customer profiles1 record
Kanha Biogenetic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Kanha Biogenetic partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Kanha Biogenetic competitors and assessment
Company assessmentDirect peers
- Eris Lifesciences: India-based mid-sized pharma manufacturer with a similar focus on branded generics, multiple dosage forms, and chronic therapy segments. Highly comparable in scale, product breadth, and domestic Indian distribution orientation.
- Unichem Laboratories: Mid-sized Indian manufacturer focused on finished dosage forms including tablets, capsules, and injectables with active domestic and export businesses. Comparable in size, regulatory orientation, and product breadth.
- Vivimed Labs: Indian pharma and specialty chemicals company manufacturing APIs and finished dosage forms. Similar mid-sized profile with overlapping customer types including nutraceuticals and OTC channels.
- Wanbury Limited: Indian pharma manufacturer focused on APIs and formulations across multiple therapeutic categories. Comparable size and product range with exposure to domestic and semi-regulated export markets.
- Centrient Pharmaceuticals: India-anchored pharma manufacturer producing generic APIs and finished dosage forms for global markets. Comparable in operating geography, regulatory focus, and core pharma manufacturing activities.
- Indoco Remedies: Indian pharma manufacturer producing tablets, capsules, ointments, and syrups for domestic and export markets. Similar mid-tier scale with overlapping dosage form portfolio and similar dependence on the Indian generics market.
- RPG Life Sciences: Indian pharma company producing finished dosage forms and nutraceuticals with a domestic and select export presence. Comparable mid-sized positioning and similar dependence on Indian market formulation sales.
- Bajaj Healthcare: Indian manufacturer of APIs, intermediates, and finished dosage forms. Similar mid-tier scale, multi-decade history, and overlapping dosage form capabilities for the domestic and emerging market channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Kanha Biogenetic social profiles
Digital presenceKanha Biogenetic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kanha Biogenetic leadership team
Management profileNumber of profiles
Profiles1 record
Kanha Biogenetic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kanha Biogenetic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kanha Biogenetic
What does Kanha Biogenetic do?
Kanha Biogenetic is a pharmaceutical manufacturer that produces tablets, capsules, dry syrups, ointments, food supplements, and nutraceuticals. The company operates a manufacturing facility in Solan, Himachal Pradesh, India, and supplies formulations to business buyers in the pharmaceutical value chain.
When was Kanha Biogenetic founded?
Kanha Biogenetic was founded in 2006. It employs 501 to 1,000 people.
Where is Kanha Biogenetic based?
Kanha Biogenetic is headquartered in Solan, India, in the Asia region.
Who are Kanha Biogenetic's main competitors?
Direct peers on record are Eris Lifesciences, Unichem Laboratories, Vivimed Labs, Wanbury Limited, Centrient Pharmaceuticals, Indoco Remedies, RPG Life Sciences and Bajaj Healthcare.
Does Kanha Biogenetic have an API?
No public API is recorded for Kanha Biogenetic.
What industry is Kanha Biogenetic in?
Kanha Biogenetic's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIACAF, Pulmonology & Allergy Specialty Pharmaceuticals. Its NAICS code is 325411 and its SIC code is 2833.